Integration of new or experimental treatment options and new approaches to clinical trials
Open Access
- 1 October 2005
- journal article
- review article
- Published by Elsevier BV in Annals of Oncology
- Vol. 16, viii30-viii35
- https://doi.org/10.1093/annonc/mdi964
Abstract
1ANZGOG (Australia–New Zealand); 2AGO-OVAR (Germany); 3NSGO (Scandinavia); 4GOG (USA); 5EORTC (Europe); 6GEICO (Spain); 7MRC/NCRI (UK); 8NCIC-CTG (Canada); 9IGCS; 10GINECO (France); 11NCI-US (USA); 12SGCTG (Scotland, UK)Keywords
This publication has 17 references indexed in Scilit:
- A pivotal phase III trial to evaluate the efficacy and safety of adjuvant treatment with R1549 (yttrium-90-labeled HMFG1 murine monoclonal antibody) in epithelial ovarian cancer (EOC)Journal of Clinical Oncology, 2004
- Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Randomized StudyJournal of Clinical Oncology, 2004
- Consolidation treatment of advanced ovarian carcinoma with radiotherapy after induction chemotherapyInternational Journal of Gynecologic Cancer, 2003
- Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapyInternational Journal of Gynecologic Cancer, 2003
- A Randomized Clinical Trial of Cisplatin/Paclitaxel Versus Carboplatin/Paclitaxel as First-Line Treatment of Ovarian CancerJNCI Journal of the National Cancer Institute, 2003
- Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2003
- Intraperitoneal Radioactive Phosphorus (32P) Versus Observation After Negative Second-Look Laparotomy for Stage III Ovarian Carcinoma: A Randomized Trial of the Gynecologic Oncology GroupJournal of Clinical Oncology, 2003
- Phase III Randomized Trial of 12 Versus 3 Months of Maintenance Paclitaxel in Patients With Advanced Ovarian Cancer After Complete Response to Platinum and Paclitaxel-Based Chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group TrialJournal of Clinical Oncology, 2003
- A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinomaAnnals of Oncology, 1997
- Is There a Role for Consolidation or Salvage Radiotherapy after Chemotherapy in Advanced Epithelial Ovarian Cancer?Gynecologic Oncology, 1993